TBIO - トランスジェノミック (Translate Bio Inc.)

TBIOのニュース

   Translate Bio Inc (TBIO) CEO Ronald C Jr Renaud Sold $36.3 million of Shares  2021/09/15 14:15:02 GuruFocus
Related Stocks: TBIO ,
   Sanofi completes acquisition of Translate Bio, accelerating the application of mRNA in new vaccines and therapeutics  2021/09/14 13:26:00 Intrado Digital Media
Sanofi completes acquisition of Translate Bio, accelerating the application of mRNA in new vaccines and therapeutics
   Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)  2021/09/08 20:30:00 Intrado Digital Media
LEXINGTON, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat or prevent debilitating or life-threatening diseases, today reported that on September 8, 2021, the Company granted restricted stock units for an aggregate of 54,078 shares of the Companys common stock to twenty new employees. These grants were made pursuant to the Companys 2021 Inducement Stock Incentive Plan, were approved by the Companys compensation committee of the board of directors, and were made as a material inducement to each employees acceptance of employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4) as a component of his or her employment compensation.
   Frances Sanofi to Buy US Biopharma Firm Kadmon in $1.9 Billion Deal  2021/09/08 10:27:29 The Epoch Times
PARISFrench drugmaker Sanofi said on Wednesday it would buy U.S. biopharmaceutical company Kadmon Holdings for 1.9 billion dollars, one month after announcing the purchase of another US biotech, Translate Bio, for $3.2 billion. Sanofi said it has offered $9.50 per share in cash for Kadmon, representing a total equity value of approximately $1.9 billion on []
   Sanofi withdraws, refiles Translate Bio acquisition with U.S. antitrust regulators  2021/08/30 14:20:32 Seeking Alpha
   Translate Bio gets $50M mRNA vaccine program milestone payment from Sanofi Pasteur  2021/06/07 11:58:34 Seeking Alpha
   Translate Bio Inc (TBIO) falls 2.22% for May 19  2021/05/19 22:00:02 Equities
Translate Bio Inc (NASDAQ: TBIO) shares fell -2.22% to end trading Wednesday at $17.19 per share - a net change of $-0.39. Shares traded between $17.45 and $16.87 throughout the day. 435896 shares of Translate Bio Inc exchanged hands. Visit Translate Bio Incs profile for more information. About The Nasdaq Stock Market The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world\''s leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook. To get more information on Translate Bio Inc and to follow the companys latest updates, you can visit the companys profile page here: Translate Bio Incs Profile . For more news on the financial markets be sure to visit Equities News . Also, dont forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week. Sources: Chart is provided by TradingView based on 15-minute-delayed prices.
   Translate Bio''s mRNA Therapeutic For Respiratory Tract Infections Shows Promise In Animal Studies  2021/05/18 18:40:59 Benzinga
Translate Bio Inc (NASDAQ: TBIO ) has presented positive results from a preclinical study of its mRNA-based therapeutic designed to treat the pulmonary component of primary ciliary dyskinesia (PCD). Mutations in the genes that cause PCD result in ineffective mucociliary clearance, which can lead to lung disease. The data were presented at Full story available on Benzinga.com
   Translate Bio (TBIO) Investor Presentation - Slideshow  2021/05/17 18:51:34 Seeking Alpha
   Translate Bio Inc. Shares Close the Week 33.1% Lower - Weekly Wrap  2021/03/19 22:30:00 Kwhen Finance
Translate Bio Inc. shares closed this week 33.1% lower than it did at the end of last week. The stock is currently down 10.7% year-to-date, up 68.4% over the past 12 months, and up 507.1% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 0.8%. Trading Activity Shares traded as high as $26.30 and as low as $16.38 this week.Shares closed 5e+1% below its 52-week high and 1e+2% above its 52-week low.Trading volume this week was 220.5% higher than the 10-day average and 466.2% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price lags the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price lags the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -225.1% The company's stock price performance over the past 12 months lags the peer average by -30.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Translate Bio gets $50M mRNA vaccine program milestone payment from Sanofi Pasteur  2021/06/07 11:58:34 Seeking Alpha
   Translate Bio Inc (TBIO) falls 2.22% for May 19  2021/05/19 22:00:02 Equities
Translate Bio Inc (NASDAQ: TBIO) shares fell -2.22% to end trading Wednesday at $17.19 per share - a net change of $-0.39. Shares traded between $17.45 and $16.87 throughout the day. 435896 shares of Translate Bio Inc exchanged hands. Visit Translate Bio Incs profile for more information. About The Nasdaq Stock Market The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world\''s leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook. To get more information on Translate Bio Inc and to follow the companys latest updates, you can visit the companys profile page here: Translate Bio Incs Profile . For more news on the financial markets be sure to visit Equities News . Also, dont forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week. Sources: Chart is provided by TradingView based on 15-minute-delayed prices.
   Translate Bio''s mRNA Therapeutic For Respiratory Tract Infections Shows Promise In Animal Studies  2021/05/18 18:40:59 Benzinga
Translate Bio Inc (NASDAQ: TBIO ) has presented positive results from a preclinical study of its mRNA-based therapeutic designed to treat the pulmonary component of primary ciliary dyskinesia (PCD). Mutations in the genes that cause PCD result in ineffective mucociliary clearance, which can lead to lung disease. The data were presented at Full story available on Benzinga.com
   Translate Bio (TBIO) Investor Presentation - Slideshow  2021/05/17 18:51:34 Seeking Alpha
   Translate Bio Inc. Shares Close the Week 33.1% Lower - Weekly Wrap  2021/03/19 22:30:00 Kwhen Finance
Translate Bio Inc. shares closed this week 33.1% lower than it did at the end of last week. The stock is currently down 10.7% year-to-date, up 68.4% over the past 12 months, and up 507.1% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 0.8%. Trading Activity Shares traded as high as $26.30 and as low as $16.38 this week.Shares closed 5e+1% below its 52-week high and 1e+2% above its 52-week low.Trading volume this week was 220.5% higher than the 10-day average and 466.2% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price lags the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price lags the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -225.1% The company's stock price performance over the past 12 months lags the peer average by -30.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

calendar